Business

Al Hammadi to acquire 35% of Sudair Pharmaceutical


Author: 
Sun, 2021-10-10 18:03

The General Authority for Competition announced its approval for the conclusion of the economic concentration process between Al Hammadi Company for Development and Investment and Sudair Pharmaceutical Co.

Al Hammadi for Development and Investment acquired 35 percent of Sudair Pharmaceuticals’ shares.

Main category: 



READ SOURCE

See also  Oil pares losses as OPEC+ sees no need for supply hikes

Leave a Reply